共 50 条
- [25] Cost-Effectiveness Analysis of Maintenance Olaparib in Patients with Metastatic Pancreatic Cancer and a Germline BRCA1/2 Mutation Based on the POLO Trial CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12919 - 12926
- [27] NICE guidance on olaparib for maintenance treatment of patients with relapsed, platinum-sensitive, BRCA mutation-positive ovarian cancer LANCET ONCOLOGY, 2016, 17 (03): : 277 - 278